Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the Respiratory Surveillance Program study: Microbiology from the medical office practice environment

American Journal of Medicine

Volumn 111, Issue 9 SUPPL. 1, 2001, Pages 4-12

  Pfaller, Michael A ^a   Ehrhardt, Anton F ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFPROZIL; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BRONCHITIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; FREQUENCY MODULATION; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MICROBIOLOGY; MORAXELLA CATARRHALIS; NASOPHARYNX; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SINUSITIS; SPECTRUM; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 0035905361     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(01)01025-7     Document Type: Article

References (16)

1. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
2. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
3. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
4. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated in Asia and Europe 1997-1998
5. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
6. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: A prospective US study
7. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)
8. World-wide prevalence of antimicrobial resistance with Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis - SENTRY Antimicrobial Surveillance Program 1997-99
9. Epidemiology and treatment of chronic bronchitis and its exacerbations
10. Community-acquired pneumonia in adults: Guidelines for management
11. The microbial ecology and antimicrobial therapy of adults with community-acquired sinusitis: A fifteen-year experience at the University of Virginia and review of other selected studies
12. Advances in antimicrobial therapy of community-acquired pneumonia
13. The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: Fluoroquinolone pharmacodynamics against Streptococcus pneumoniae